Patent ID: 11905281
Assignee: AMGEN INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 7:
8. A process of making a compound, wherein the compound is, or a pharmaceutically acceptable salt thereof, and wherein the process comprises
(a) transforming 2,6-dichloro-5-fluoro-nicotinic acid into 2,6-dichloro-5-fluoronicotinamide;
(b) transforming 2,6-dichloro-5-fluoronicotinamide into the compound of claim 2;
(c) transforming the compound of claim 2 into the compound of claim 3;
(d) transforming the compound of claim 3 into the compound of claim 4;
(e) transforming the compound of claim 4 into the compound of claim 5;
transforming the compound of claim 5 into the compound of claim 6; or
(g) transforming the compound of claim 6 into the compound of claim 7.